INTRODUCTION
The family Juncaceae comprises about 500 species worldwide, which are distributed into seven genera. Species of the family are widely distributed on both hemispheres, the two largest, cosmopolitan genera of the family are Juncus L. (n = 347) and Luzula DC. (n = 115). There are 15 Juncus and 6 Luzula species native to Hungary.
The phytochemical investigations of Juncus plants resulted in the isolation of several different secondary plant metabolites (e.g. coumarins, flavonoids, phenanthrenes and terpenoids). Among them phenanthrenes and 9,10-dihydrophenanthrenes are the most characteristic constituents.
Phenanthrenes are considered to comprise a relatively small group of natural products. According to the most accepted hypothesis, the phenanthrene skeleton can be formed by oxidative coupling of the aromatic rings of stilbene precursors.
These compounds have drawn considerable interest from the aspect of natural product drug discovery because of the wide range of their potentially valuable biological activities and their broad structural diversity. Up to date more than 450 compounds have been isolated from higher plants and liverwort species. As a result of the intense phytochemical examination on phenanthrene-containing plants almost 50% of the naturally occurring phenanthrenes were identified during the last ten years.
Until now only five species belonging to the genus Juncus were investigated extensively and almost one hundred novel phenanthrenes have been isolated from these species. There is a significant lack of information with regard to chemical constituents of the plants belonging to the genus Luzula. Previously only the flavonoid components of Luzula species were identified by the use of thin layer chromatography.
Various Juncus species are used in the traditional medicine for the treatment of numerous conditions (e.g. cold, sleep disorders). In several cases, the folk medicinal use of the plants was confirmed by pharmacological investigations. Phenanthrenes isolated from different Juncaceae species exert many different activities, including antitumor, anti-inflammatory, antioxidant, anxiolytic, cell-protective, sedative, and spasmolytic effects.
Phenanthrenes are considered to be important taxonomic markers, because of their limited occurrence.
AIMS OF THE STUDY
A few years ago a research program has been started in the Department of Pharmacognosy, University of Szeged with the aim of investigating the secondary metabolites of plants belonging to the family Juncaceae. The objectives of the present work -as part of this project -were the isolation and structural characterization of phenanthrenes, and investigation of their pharmacological effects. In order to achieve the aims, the main tasks of the presented study were:
• Review the literature of the naturally occurring phenanthrenes.
• Overview the chemical and pharmacological properties of the plants of the family Juncaceae.
• Preparation of extracts with different polarity in order to perform pharmacological and chemical screening of the extracts of Juncaceae species (altogether 19 species).
• In vitro screening of the extracts for antibacterial effect on resistant bacterial strains, and determination of their MIC values.
• In vitro screening of the Luzula species for anti-inflammatory effects on fMLP/CB-induced human neutrophils.
• Detailed phytochemical analysis of Juncus inflexus L. and Luzula luzuloides (Lam.) Dandy & Wilmott, using a bioactivity-guided approach to identify active fractions and components.
• Provide characteristic spectral data on the isolated compounds, and structure elucidation of the isolated components.
• Determination of the absolute configuration of the chiral compounds.
• Prediction of possible biosynthetic pathways by semi-synthetic approaches.
• Evaluation of the pharmacological potential and chemotaxonomical relevance of the isolated compounds.
MATERIALS AND METHODS
Plants [Juncus acutus L., J. alpinoarticulatus Chaix, J. articulatus L., J. compressus The anti-inflammatory properties of the Luzula extracts and the pure compounds were determined by testing their inhibitory effects on superoxide anion generation and elastase release on fMLP/CB-induced human neutrophils.
RESULTS AND DISCUSSION

SCREENING OF JUNCACEAE SPECIES FOR ANTIBACTERIAL ACTIVITY
As part of our screening program for biologically active compounds in Juncaceae plants occurring in the Carpathian Basin 96 extracts with different polarity were prepared from 19 species of the family in order to evaluate their antibacterial effects.
First methanol extracts were prepared from whole plants, or where it was possible from different plant parts (aerial part, root). After filtration and evaporation, the residues were dissolved in 50% aqueous MeOH and were subjected to solventsolvent partition between n-hexane (extracts A), CH2Cl2 (extracts B) and EtOAc (extracts C); and the remaining H2O extracts were named as extracts D.
All fractions were tested for their antibacterial activity against 10 multiresistant bacterial strains. The activities of extracts were screened at first for their inhibitory zones by disc-diffusion method at concentrations of 50 mg/mL. 16 Fractions (CH2Cl2 and remaining H2O) from Juncus species and 3 CH2Cl2-soluble fractions from Luzula species possessed mild to strong inhibitory activities against MRSA strains (inhibition zones = 6.7 mm -14.6 mm). A total of 6 extracts had diameters of inhibition zone ≥10 mm, therefore these were studied further to determine their minimal inhibitory concentrations (MICs) by the microdilution method. The most active fractions were exclusively fractions B (containing CH2Cl2-soluble lipophilic constituents). Among them, the CH2Cl2-soluble fraction of the roots of J. inflexus showed the highest activity (MIC = 9.75 μg/mL). Fraction B of the roots of J. effusus displayed significant anti-MRSA activity (MIC = 39 μg/mL). The CH2Cl2-soluble fraction of J. maritimus and J. gerardii possessed marked activity (MIC = 78 μg/mL, for both extracts), and mild anti-MRSA activities were observed for fraction B of J. acutus and for fraction B prepared from the aerial parts of J. tenuis (MIC = 156 μg/mL, for both extracts). The antibacterial activity of the species belonging to the genus Juncus was more significant (inhibition zones = 7.6 mm -14.6 mm) than the activity of the species of genus Luzula (inhibition zones = 6.7 mm -7.3 mm). The difference of the chemical composition between the two genera could serve as an explanation for the different activities.
According to the preliminary screening results J. inflexus has been chosen for further studies.
SCREENING OF JUNCACEAE SPECIES FOR ANTI-INFLAMMATORY ACTIVITY
In the course of investigation of anti-inflammatory activity, 24 extracts (n-hexane On the basis of these results, L. luzuloides has been selected for further investigations.
ISOLATION OF BIOACTIVE COMPOUNDS FROM J. INFLEXUS AND L. LUZULOIDES
In the initial step of the phytochemical work, the dried plant materials were percolated with MeOH at room temperature, and then solvent-solvent partition was applied, which resulted in the CH2Cl2 phases. The CH2Cl2-soluble fractions were subjected to a multistep chromatographic procedure in order to isolate the compounds.
ISOLATION OF COMPOUNDS FROM J. INFLEXUS
The CH2Cl2 fraction of the roots of J. inflexus was chromatographed on a polyamide column (OCC) with mixtures of MeOH and H2O (2:3, 1:1, 3:2, 4:1, 1:0; each eluent was collected as a fraction). The composition of the fractions obtained from the polyamide column with methanol-water 3:2 and 4:1 was similar, therefore these fractions were combined (J3). All of the fractions (J1-4) obtained from the polyamide column were subjected to antibacterial screening; among them J3 showed the strongest inhibitory activity against MRSA strains (ATCC43300 and 64326) (inhibition zones = 15.3 ± 0.6 mm and 14.3 ± 0.6 mm, respectively), while J2 (inhibition zones = 7.3 ± 0.6 mm, for both strains), J4 (inhibition zones = 7.6 ± 0.6 mm, for both strains) possessed moderate activity, and J1 was proved to be inactive. As a result of the NMR studies, complete 1 H-and 13 C-assignments were made for the new compounds and also in case of some known compounds, where previously published data were incomplete.
The absolute configurations of the chiral compounds were determined using chiral HPLC separation and circular dichroism (CD) experiments.
COMPOUNDS FROM JUNCUS INFLEXUS
From the CH2Cl2-soluble fraction of J. inflexus 12 compounds, 11 phenanthrenes (1-11) and a flavonoid (12) were isolated with the combination of different chromatographic techniques.
Four phenanthrenes (jinflexins A-D, 1-4) are new natural products. Jinflexin A (JIN-7, 1) is a methoxyethyl substituted 9,10-dihydrophenanthrene, from which the vinyl group is missing, but the position of the methoxyethyl group suggests that biogenetically this compound was also vinylated. Its zero specific rotation and the baseline ECD spectrum adding to the results of the chiral HPLC analysis confirmed that jinflexin A (1) is a racemic mixture. Jinflexin B (JIN-12, 2) is also specific, as its 9,10-dihydrophenanthrene core is substituted with an oxymethylene group at C-1.
Moreover, it has a methoxy substitution at C-2, which is a quite unusual position for this group among Juncaceae phenanthrenes. Jinflexin C (JIN-15, 3) is a carbonyl (C-1) substituted 5,6,9,10-tetrahydrophenanthrene, not only its core is unusual, but the presence of a methyl and a vinyl group at the same carbon (C-7) also contributes to its unique structure. On the basis of the TDDFT-ECD calculations and chiral HPLC analysis, jinflexin C (3) is a 6R,7R enantiomer with 80% enantiomeric excess (ee).
Jinflexin D (JIN-19, 4) is a dimer with an unprecedented heptacyclic ring system, which may be considered to derive by the coupling of dehydrojuncuenin A (9) with 2,7-dihydroxy-1,8-dimethyl-5-vinyl-9,10-dihydrophenanthrene through their vinyl groups forming a unique structure. The chiral HPLC analysis of jinflexin D (4) showed 9% ee. The absolute configuration of the first-eluting enantiomer of 4 was identified as (R). The enantiomeric excess came from the second-eluting enantiomer, which was therefore determined as (S). were also isolated from the roots of J. inflexus. Among the known phenanthrenes, six compounds can be paired, based on the saturation of the C-9-C-10 bond.
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The substitution pattern of dehydrojuncuenin A (9) and juncuenin A (5); dehydrojuncuenin B (11) and juncuenin B (6); dehydrojuncusol (10) and juncusol (7) are the same, the first member of the pairs are phenanthrenes, and the second ones are their 9,10-dihydro analogues. Juncuenin D (8) is a phenanthrenequinone presumably derived from juncuenin B (6) . The absolute configuration of juncuenin D (8) was also determined, and its (S) enantiomer has 4% of enantiomeric excess.
COMPOUNDS FROM LUZULA LUZULOIDES
The structure analysis of compounds isolated from L. luzuloides led to the were also isolated from the apolar fraction of the plant. All of the compounds were identified for the first time in L. luzuloides, and this was the first time when phenanthrenes were isolated from a species belonging the genus Luzula.
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BIOSYNTHETIC PATHWAYS
Considerable amount of juncuenin B (6) (850 mg) has been isolated from J. inflexus, hence it can be considered as the main compound of the root. In our studies juncuenin B (6) 
BIOACTIVITY OF THE ISOLATED COMPOUNDS ANTIBACTERIAL ACTIVITY
In our preliminary screening, the CH2Cl2 fraction of J. inflexus exerted the most potent antibacterial activity against MRSA strains. Therefore, it was subjected to a comprehensive preparative phytochemical analysis. The compounds isolated from this fraction were tested for their anti-MRSA activity at concentration of 10 mg/mL (in Table 1 only the active compounds were mentioned). Among the isolated phenanthrenes, noteworthy inhibitory activities were recorded for jinflexin B (2), juncusol (7), juncuenin D (8) and dehydrojuncuenin B (11). 
ANTI-INFLAMMATORY ACTIVITY
Compounds from L. luzuloides and the semisynthetically obtained juncuenin D (8) were evaluated for their anti-inflammatory properties using superoxide anion generation and elastase release inhibition assays ( Table 2 ). In the superoxide anion generation assay, significant inhibitory activities were recorded for juncuenin B (6) (IC50 = 4.92 µM), juncusol (7) (IC50 = 3.11 µM), dehydrojuncuenin B (11) (IC50 = 3.17 µM), apigenin (14) (IC50 = 6.12 µM) and luteolin (15) (IC50 = 4.73 µM). (n=3-5) . * P < 0.05, ** P < 0.01, *** P < 0.001 compared with the control value. LY294002, a PI3K inhibitor, was used as positive control.
Furthermore, juncuenin B (6) and luteolin (15) inhibited effectively the elastase release with IC50s of 5.47 µM and 6.91 µM, respectively, comparable to that of the positive control (LY294002, 4.79 µM). Juncusol (7), dehydrojuncuenin B (11) and apigenin (14) were considered to be inactive on the elastase release, while juncuenin D (8) and luzulin A (13) were proved to be inactive in both assays.
Juncuenin B (6) lost its effect on the elastase release by the unsaturation of ring B, but dehydrojuncuenin B (11) inhibited the superoxide generation slightly effectively than juncuenin B (6). The phenanthrenequinones, juncuenin D (8) and luzulin A (13), presumably derived from juncuenin B (6), showed significantly lower anti-inflammatory activities compared to their possible biosynthetic precursor.
HPLC-MS INVESTIGATION OF EXTRACTS
Bioassay-guided fractionation of J. inflexus resulted in the isolation of four phenanthrenes [jinflexin B (2) , juncusol (7) All of these compounds were detected in the CH2Cl2 fraction of J. inflexus, which suggests that these components were originally in the plant, instead of evolving during the purification process.
Juncusol (7) was identified in all the investigated extracts, and the presence of jinflexin B (2) was confirmed in the CH2Cl2-soluble extracts of J. acutus and J. gerardii.
The detected active compounds could play an important role in the antibacterial effects of the extracts, which can involve different pharmacological mechanisms.
However, the chemical composition of J. gerardii, J. maritimus and J. tenuis were not studied thoroughly; therefore, some other, unidentified compounds may also play role in the activities of these extracts. Vinyl substituted derivatives can be considered as chemotaxonomic markers for plants belonging to family Juncaceae, since these specifically substituted phenanthrenes were reported previously only from Juncus species, and this was the first time when they were isolated from the genus Luzula. 
CHEMOTAXONOMY
